GlobalIPNews

Sign Up
|
Login
|

15:58:07 Mon 23 Feb 2026

Home
About Us
Industry
Assignee
Country
Support
Products
Services
View ALl

News For Last 1 Week

Industry

X

Assignee

X

Tianjin University

(52)

Shanghai Jiao Tong Univer

(44)

Rna Therapeutics Inc

(14)

Hangzhou Yisikang Pharmac

(13)

China Pharmaceutical Univ

(11)

Tianjin University of Tec

(10)

Shenyang Pharmaceutical U

(9)

Eli Lilly and Company

(8)

(7)

Chia Tai Tianqing Pharmac

(7)

Jiangsu Kanion Pharmaceut

(7)

Tecon Biopharmaceutical C

(6)

Hoffmann La Roche

(5)

PLA Air Force Medical Uni

(5)

Regeneron Pharmaceuticals

(5)

Renji Hospital Shanghai J

(5)

Tianjin University of Sci

(5)

Assembly Biosciences

(4)

Beijing University of Chi

(4)

Changchun GeneScience Pha

(4)

(4)

Hoffmann-La Roche

(4)

(4)

Institute Military Medici

(4)

Jiangsu Hengrui Medicine;

(4)

Otsuka Pharmaceutical

(4)

Takeda Pharmaceuticals

(4)

Welcome to Northwest A&F

(4)

Wuhan Polytechnic Univers

(4)

Anhui Jilekang Pharmaceut

(3)

Boehringer Ingelheim Inte

(3)

Changxing Dongfang Tradit

(3)

Chengdu University of Tra

(3)

China Japan Friendship Ho

(3)

China Resources Sanjiu Me

(3)

Deciphera Pharmaceuticals

(3)

Fourth Hospital of Hebei

(3)

Fudan University

(3)

Fujian Bonuo Anke Pharmac

(3)

Guizhou University

(3)

Hainan Medical Univ Haina

(3)

Henan Anjin Biotechnology

(3)

Inocur Therapeutics Inc

(3)

Institute of Materia Medi

(3)

Jazz Pharmaceuticals Irel

(3)

Kymera Therapeutics

(3)

Lanzhou Institute Husband

(3)

Meilan Hangzhou Pharmaceu

(3)

Merck Sharp & Dohme

(3)

Methodist Hospital [us];

(3)

Nimbus Saturn Inc

(3)

Poseida Therapeutics

(3)

Shaanxi University of Sci

(3)

Shandong University

(3)

Shandong University of Te

(3)

Shandong University of Tr

(3)

Shanghai 9th People\'s Ho

(3)

Shanghai Huanma Biologica

(3)

Shanghai Inst Of Pharmace

(3)

Shanghai Investigation De

(3)

The Second Xiangya Hospit

(3)

Tianjin University; Hisen

(3)

University Yunnan Traditi

(3)

Wyvern Pharmaceuticals

(3)

Zhangzhou Pien Tze Huang

(3)

Zhejiang Zhongke Chuangyu

(3)

Zhucheng Haotian Pharmace

(3)

Adcentrx Therapeutics Inc

(2)

Agrichina Pharmaceutical

(2)

Aimei Jianchi Biological

(2)

Amylyx Pharmaceuticals

(2)

Anhui Medical University

(2)

Arcturus Therapeutics

(2)

Arrowhead Pharmaceuticals

(2)

Basilea Pharmaceutica Int

(2)

Bausch+Stroebel

(2)

Beech Biotech Sa

(2)

Beijing Inno Medicine Co

(2)

Beijing Youan Hospital, C

(2)

Bide Pharmatech Co Ltd

(2)

China Academy of Chinese

(2)

China Resources Biomedica

(2)

China Three Gorges Univer

(2)

Chongqing Bull Animal Pha

(2)

Chongqing Medical Univers

(2)

Chongqing Traditional Chi

(2)

(2)

Cymabay Therapeutics Inc

(2)

Dalian University of Tech

(2)

(2)

Electric Power Research I

(2)

(2)

(2)

Gannan Medical University

(2)

Gansu Digital Herbal Exam

(2)

Gibson Oncology Llc

(2)

GlaxoSmithKline Biologica

(2)

GlaxoSmithKline Intellect

(2)

Global Health Solutions I

(2)

Guangdong Yifang Pharmace

(2)

Guangzhou Lianrui Pharmac

(2)

Haisco Pharmaceutical Gro

(2)

Hanmi Pharmaceutical

(2)

Hebei Anjian Chengyi Phar

(2)

Huaneng Tibet Yarlung Zan

(2)

Hunan Kelun Pharmaceutica

(2)

Institute of Chinese Mate

(2)

Janssen Biotech

(2)

Jiangsu Food & Pharmaceut

(2)

Jiangxi Universe Pharmace

(2)

Jinju Biological Medicine

(2)

Kate Therapeutics Inc

(2)

Lane Hsien Yuan [tw]; Lin

(2)

Laxmi Therapeutic Devices

(2)

Liaoning Cancer Hospital

(2)

Lunan Pharmaceutical Grou

(2)

Medicon Pharmaceuticals

(2)

Medshine Discovery

(2)

(2)

Miaowang Pharmaceutical G

(2)

Modern Chinese Medicine H

(2)

Nanjing Drum Tower Hospit

(2)

Nanjing King Friend Bioch

(2)

Nanjing Zeheng Pharmaceut

(2)

(2)

Ningxia Zhouyang Pharmace

(2)

No 1 Affiliated Hospital

(2)

Nocturna Therapeutics Sl

(2)

(2)

(2)

Ovid Therapeutics

(2)

(2)

Prospect Therapeutics Nan

(2)

Qilu Pharmaceutical Inner

(2)

Qufu Shengren Pharmaceuti

(2)

Ruijin Hospital Shanghai

(2)

Ruijin Hospital Shanghai

(2)

Sanofi-Aventis Deutschlan

(2)

Shandong Chengkang Pharma

(2)

Shandong Qiyueshang Biolo

(2)

Shanghai Cancer Inst; Eas

(2)

Shanghai Hansoh Biomedica

(2)

Shanghai Institute of Mat

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jiao Tong Univer

(2)

Shanghai Jinfukang Pharma

(2)

Shanghai Meiyue Biotech D

(2)

Shanxi Shuangyan Pharmace

(2)

Shenzhen Shuimu Biologica

(2)

Sichuan Xieli Pharmaceuti

(2)

Soochow University

(2)

Sorrento Therapeutics Inc

(2)

State Grid Shanghai Munic

(2)

Suzhou Dawnrays Pharmaceu

(2)

Suzhou Yilian Biological

(2)

Suzhou Youseen New Drug R

(2)

The Second Hospital of Da

(2)

Tianjin University of Com

(2)

Tianjin University of Tec

(2)

Tianjin University of Tra

(2)

Tianjin University; Elect

(2)

Tongji Medical College Ho

(2)

Tsinghua University

(2)

Univ Macau Sci & Tech

(2)

Vertex Pharmaceuticals

(2)

Wuhan Jiuzhou Yumin Pharm

(2)

Xinqikang Pharmaceutical

(2)

Xiyuan Hospital of China

(2)

Yangpu Jingtai Pharmaceut

(2)

Yantai Institute Coastal

(2)

Yuyama Manufacturing

(2)

(2)

Zhejiang Hisun Pharmaceut

(2)

Zhejiang Provincial Peopl

(2)

Zhejiang Subkom Pharmaceu

(2)

Zhongke Zhongshan Pharmac

(2)

Zhongxin Biopharmaceutica

(2)

(1)

26 2016 Pharmaceutical Co

(1)

4M Therapeutics

(1)

6j Biotechnology Hong Kon

(1)

(1)

ADS Therapeutics

(1)

Aardvark Therapeutics

(1)

Acai Therapeutics

(1)

Acelink Therapeutics Inc

(1)

Add Advanced Drug Deliver

(1)

Adneuris Therapeutics Inc

(1)

Adsentex Therapeutics Inc

(1)

Adst Xiamen Tech Co Ltd;

(1)

Advaccine Suzhou Biopharm

(1)

Affiliated Hospital of Sh

(1)

Affiliated Hospital of So

(1)

Affiliated Hospital of Ya

(1)

Affiliated Hospital of Zu

(1)

Agrovet Market S A

(1)

Aimed Bio Inc [kr]; Samsu

(1)

Aiyi Life Tech Guangdong

(1)

(1)

Alexion Pharmaceuticals

(1)

Alicorn Pharmaceutical Co

(1)

Alnylam Pharmaceuticals

(1)

Alpha Pharmaceutical Co L

(1)

(1)

Amylyx Pharmaceuticals In

(1)

(1)

Anebulo Pharmaceuticals

(1)

Anguo Hongren Pharmaceuti

(1)

Anguo Shenhao Pharmaceuti

(1)

Anhui Chuwang Pharmaceuti

(1)

Anhui Dechang Pharmaceuti

(1)

Anhui Funland Biological

(1)

Anhui Guixin Linyan Pharm

(1)

Anhui Heryi Pharmaceutica

(1)

Anhui Jiahe Traditional C

(1)

Anhui Jinyuan Pharmaceuti

(1)

Anhui Punuo Pharmaceutica

(1)

Anhui Ruibai Pharmaceutic

(1)

Anhui Yirenan Co Ltd

(1)

Anhui Yuanhe Biopharmaceu

(1)

Anhui Zhishentang Pharmac

(1)

Animal Microbiome Analyti

(1)

Ansheng Shanghai Pharmace

(1)

Antharis Therapeutics Inc

(1)

Aonuo China Pharmaceutica

(1)

Apogee Biotechnology Corp

(1)

(1)

Arena Pharmaceuticals

(1)

Aris Pharma Gmbh

(1)

Arizona Board Of Regents

(1)

Armata Pharmaceuticals

(1)

Army Medical University

(1)

Arroyo Redondo Julio Cesa

(1)

Arti Pharmaceuticals Llc

(1)

Arvinas Operations; Pfize

(1)

Asan Found [kr]; Universi

(1)

Asieris Pharmaceuticals S

(1)

Aska Pharmaceutical Co Lt

(1)

Astellas Inst For Regener

(1)

Astra Kine Therapeutics I

(1)

AstraZeneca Sweden AB

(1)

AstraZeneca Sweden AB; Mi

(1)

Atai Therapeutics

(1)

Atoms For Cure Gmbh

(1)

Avelos Therapeutics Inc

(1)

(1)

Axsome Therapeutics

(1)

Azurity Pharmaceuticals

(1)

B A I Biosciences Inc

(1)

(1)

Baerenkraft Therapeutics

(1)

Bailite Biopharmaceutical

(1)

Baochun Sichuan Pharmaceu

(1)

Baoji City Hospital Of Tr

(1)

Baoshan Iron & Steel; Sha

(1)

(1)

Beihua University

(1)

Beijing 100biotech Co Ltd

(1)

Beijing Advocate Biotechn

(1)

Beijing Anbo Ruida Pharma

(1)

Beijing Biostar Pharmaceu

(1)

Beijing Collab Pharma Co

(1)

Beijing Funuoming Pharmac

(1)

Beijing Guohua Xinye Trad

(1)

Beijing Hospital of Tradi

(1)

Beijing Huada Biotech And

(1)

Beijing Huironghe Technol

(1)

Beijing Jingfeng Pharmace

(1)

Beijing Jingjia Biologica

(1)

Beijing Johamu Pharmaceut

(1)

Beijing Kangmei Pharmaceu

(1)

Beijing Kangyi Pharmaceut

(1)

Beijing Konruns Pharmaceu

(1)

Beijing Liuminru Traditio

(1)

Beijing Normal University

(1)

Beijing Normal University

(1)

Beijing Puqi Pharmaceutic

(1)

Beijing Quantum Hi Tech P

(1)

Beijing Shijitan Hospital

(1)

Beijing Shuangya Medical

(1)

Beijing Smartchip Microel

(1)

Beijing Summer Sprout Tec

(1)

Beijing Taikaier Nutritio

(1)

Beijing Tuoling Botai Bio

(1)

Beijing University

(1)

Beijing University of Che

(1)

Beijing University of Chi

(1)

Beijing Wanhui Shuanghe P

(1)

Beijing Xingdetong Pharma

(1)

Beijing Xinhualian Xiehe

(1)

Beijing Youcare Kechuang

(1)

Beijing Youcare Kechuang

(1)

Beijing Zhendong Guangmin

(1)

Beijing Zhongjian Tianxin

(1)

Beijing Zhongke Lihua Pha

(1)

Beijing Zhuohang Lishi Te

(1)

Beilai Pharmaceutical Co

(1)

Beren Therapeutics P B C

(1)

Bianshi Biological Pharma

(1)

Binzhou Medical College

(1)

BioMarin Pharmaceutical

(1)

Biocytogen Beijing Pharma

(1)

Biofront Therapeutics Bei

(1)

(1)

Biosiense Co Ltd

(1)

Bioventures Llc [us]; The

(1)

Bivision Pharmaceuticals

(1)

Boehringer Ingelheim Vetm

(1)

Bold Therapeutics

(1)

Briacell Therapeutics Cor

(1)

Bridgebio Gene Therapy Ll

(1)

Brightgene Bio Medical Te

(1)

Bristol Myers Squibb

(1)

CSPC Zhongqi Pharmaceutic

(1)

CSPC Zhongqi Pharmaceutic

(1)

Cadwell Laboratories

(1)

Cangzhou Medical College

(1)

(1)

Catalyst Pharmaceuticals

(1)

Celero Systems Inc

(1)

Cellfiber Co Ltd [jp]; Un

(1)

(1)

Center For Neuromusculosk

(1)

Central Peoples Hospital

(1)

Centre Nat Rech Scient [f

(1)

(1)

(1)

Changchun Electronic Tech

(1)

Changchun Puhua Pharmaceu

(1)

Changchun University of C

(1)

Changchun Zhenxin Chengyi

(1)

Changzhou STA Pharmaceuti

(1)

Changzhou Youkaimei Pharm

(1)

(1)

(1)

Chengdu Aidi Pharmaceutic

(1)

Chengdu Baiyu Pharmaceuti

(1)

Chengdu Chipscreen Pharma

(1)

Chengdu Easton Biopharmac

(1)

Chengdu First Pharmaceuti

(1)

Chengdu Jielong Hao Pharm

(1)

Chengdu Jinniu District M

(1)

Chengdu Kanghong Pharmace

(1)

Chengdu Medical College

(1)

Chengdu Rongsheng Pharmac

(1)

Chengdu Scimount Pharmate

(1)

Chengdu Shuilipu Pharmace

(1)

Chengdu University

(1)

Chenxiang Cultural Ind Fu

(1)

Chifeng Traditional Chine

(1)

China Airplane Strength R

(1)

China Electric Power Rese

(1)

China Energy Construction

(1)

China MCC17 Group; Shangh

(1)

China Merchants Group Tes

(1)

China Resources Sanjiu Mo

(1)

China Silicon; Tianjin Un

(1)

China State Inst Of Pharm

(1)

China Union Chempharma Su

(1)

Chinese Institutes For Me

(1)

Chinese PLA Army Speciali

(1)

Chinese University of Hon

(1)

Chongqing Aishengsi Biolo

(1)

Chongqing Hongsheng Pharm

(1)

Chongqing Jinsaixing Medi

(1)

Chongqing Minggu Faer Ent

(1)

Chongqing Pujian Pharmace

(1)

Chongqing Shilide Pharmac

(1)

Chongqing Siyong Pharmace

(1)

Chongqing University of P

(1)

Chongqing University of T

(1)

Chongqing Wanhengtang Hea

(1)

Chongqing Xingtaihao Phar

(1)

Cinclus Pharma Holding AB

(1)

Cincor Pharma Inc

(1)

Cixi Biomedical Research

(1)

Claris Biotherapeutics In

(1)

Cleanor Tech As

(1)

Click Therapeutics

(1)

Clifton Life Sciences Llc

(1)

Cn Surgical Dexterity Llc

(1)

Cognition Therapeutics In

(1)

Colgate-Palmolive Company

(1)

(1)

Commissariat Energie Atom

(1)

Convalife Shanghai Co Ltd

(1)

(1)

(1)

(1)

Council of Scientific & I

(1)

Cytocares Shanghai Inc

(1)

CytomX Therapeutics

(1)

Cytonus Therapeutics Inc

(1)

Cytonus Therapeutics Inc

(1)

Cytosite Biopharma

(1)

Czerska Barbara

(1)

DSM IP Assets B V

(1)

Daegu Catholic Univ Indus

(1)

Daewoong Pharmaceutical

(1)

Dali University

(1)

Dalian Medical University

(1)

Dalian University

(1)

Danatlas Pharmaceuticals

(1)

Dandong Xin Shi Dai Biote

(1)

Delix Therapeutics

(1)

Denovo Biopharma Ltd

(1)

Dermaliq Therapeutics Inc

(1)

Dermatology Hospital of t

(1)

Deshankui Shanxi Traditio

(1)

Dewpoint Therapeutics

(1)

Dianjing Pharmaceutical W

(1)

Diosynvax Ltd [gb]; Cambr

(1)

Donald Carlton Dewitt

(1)

(1)

Dongfang Hospital Beijing

(1)

Dongfanghong Western Gins

(1)

Dongguan Huiying Tech Co

(1)

Dongguan Jinfusheng Intel

(1)

Dongguan Mingxiong Ind Co

(1)

Dongguan People\'s Hospit

(1)

Dongguan Sudiwa Tech Co L

(1)

Dongping People\'s Hospit

(1)

Dongying Tiandong Pharmac

(1)

(1)

(1)

Duality Biologics Shangha

(1)

Duksung Womens Univ Indus

(1)

East China Normal Univers

(1)

East China Normal Univers

(1)

East China University of

(1)

Eastern Virginia Medical

(1)

Economic Technology Res I

(1)

Educational Foundation Of

(1)

Elevar Therapeutics Inc

(1)

Eliaz Therapeutics Inc [u

(1)

Elite Therapeutics Inc

(1)

Englare Therapeutics Inc

(1)

(1)

(1)

(1)

Equashield Medical

(1)

Etnova Therapeutics Corp

(1)

Experimental Res Center C

(1)

(1)

Faron Pharmaceuticals Oy

(1)

Federal State Budgetary I

(1)

Fibro Biologics Inc

(1)

Filman Labs Mfg Inc

(1)

First Affiliated Hospital

(1)

First Affiliated Hospital

(1)

First People\'s Hospital

(1)

Foghorn Therapeutics

(1)

Follea International

(1)

(1)

Fortum Waste Solutions Oy

(1)

Forward Therapeutics Inc

(1)

Foshan Dezhong Pharmaceut

(1)

Foshan Leawell Medical Te

(1)

Foundation Medicine

(1)

Fred Hutchinson Cancer Ce

(1)

Friendly Pharmaceutical

(1)

Fujian Kerui Pharmaceutic

(1)

Fujian Shengdi Pharmaceut

(1)

(1)

Fumei Zhongkang Medical T

(1)

Fuwai Hospital, Chinese A

(1)

Fuyang Normal University;

(1)

Fuzhou Adicon Clinical La

(1)

Fuzhou Juxing Photoelectr

(1)

GE Precision Medicine

(1)

(1)

Galvany Pharma Ltd

(1)

Ganjiang Traditional Chin

(1)

Gannan Normal University

(1)

Gansu Pharmaceutical Grou

(1)

Ganzhou Pharmapack Techno

(1)

(1)

Gene Tech Shanghai Compan

(1)

Genentech Inc [us]; Hoffm

(1)

General Biological Anhui

(1)

Genetic Diagnostics And T

(1)

Genome & Company Inc

(1)

Genor Biopharma Co Ltd

(1)

Genscript Nanjing Co Ltd

(1)

Georgia Tech Research Ins

(1)

Gilead Sciences

(1)

Glaxosmithkline Intellect

(1)

Glaxosmithkline Intellect

(1)

Globepharma Inc

(1)

(1)

Gongwin Biopharm

(1)

(1)

Granules India Ltd

(1)

Gritstone Bio Inc

(1)

GuangXi University

(1)

Guangdong Chenkang Biotec

(1)

Guangdong Danxia Bio Phar

(1)

Guangdong Hantian Biophar

(1)

Guangdong Hospital of Tra

(1)

Guangdong Hospital of Tra

(1)

Guangdong Inst For Drug C

(1)

Guangdong Kang Rong Ind C

(1)

Guangdong Luofushan Gehon

(1)

Guangdong Medical Univers

(1)

Guangdong P D Pharmaceuti

(1)

Guangdong Pharmaceutical

(1)

Guangdong Pharmaceutical

(1)

Guangdong Second Traditio

(1)

Guangdong Wanwuyijun Biot

(1)

Guangshengtang Zhongxing

(1)

Guangxi Fulaiming Biophar

(1)

Guangxi Guiwu Energy Savi

(1)

Guangxi Medical College

(1)

Guangxi Qinan Agarwood Bi

(1)

Guangxi Vantone Pharmaceu

(1)

Guangzhou Baiyunshan Jing

(1)

Guangzhou Baiyunshanzhong

(1)

Guangzhou Bfr Medical Exa

(1)

Guangzhou Innogen Pharmac

(1)

Guangzhou Medical Univers

(1)

Guangzhou Renheng Pharmac

(1)

Guangzhou Shengkang Biolo

(1)

Guangzhou Totem Life Medi

(1)

Guangzhou Wanglaoji Pharm

(1)

Guangzhou Yipu Biotechnol

(1)

Guangzhou Zhongtian Bio T

(1)

Guilin Sanjin Pharmaceuti

(1)

Guizhou Evergreen Pharmac

(1)

Guizhou Inst Of Animal Hu

(1)

Guizhou Jianyice Tech Co

(1)

Guizhou Kunxi Liquor Ind

(1)

Guizhou Natural Product R

(1)

Guizhou Shanhai Tongjia P

(1)

Guizhou Weiling Biotechno

(1)

Guizhou Xidengle Pharmace

(1)

Guizhou Xuanjia Miao Fang

(1)

Guojian Qingdao Testing T

(1)

Haier Bio Medical Tech Su

(1)

Hailaike Beijing Biotechn

(1)

Hainan Aike Pharmaceutica

(1)

Hainan Halee Pharmaceutic

(1)

Hainan Huluwa Pharmaceuti

(1)

Hainan Jiuchang Pharmaceu

(1)

Hainan Special Economic Z

(1)

Hainan Wandailan Biomedic

(1)

Hainan Zhikang Medical De

(1)

Hainan Zhuoli Pharmaceuti

(1)

Haisco Pharmaceutical Gro

(1)

Handa Oncology Llc

(1)

Hangzhou Adcoris Biopharm

(1)

Hangzhou AllTest Biotechn

(1)

Hangzhou Beihang Univ Int

(1)

Hangzhou Bgi Life Science

(1)

Hangzhou Bozhirui Biologi

(1)

Hangzhou Chengbang Pharma

(1)

Hangzhou City Xiaoshan Di

(1)

Hangzhou Innogate Pharma;

(1)

Hangzhou Jinchengke Healt

(1)

Hangzhou Nanfeng Pharmace

(1)

Hangzhou Red Cross Hospit

(1)

Hangzhou Shanli Biologica

(1)

Hangzhou Sinuoda Pharmace

(1)

Hangzhou Wuyuantang Biote

(1)

Hangzhou Yiyuxin Tech Dev

(1)

Hangzhou Zhongmei Huadong

(1)

(1)

(1)

Haodong Biopharmaceutical

(1)

Harbin Gaozhentang Tradit

(1)

Harbin Pharmaceutical Gro

(1)

Harbin Veterinary Researc

(1)

(1)

He Univ; Shenyang Yanchan

(1)

Hebei Huachen Pharmaceuti

(1)

Hebei Huadu Pharmaceutica

(1)

Hebei Normal University S

(1)

Hebei Sanxin Pharmaceutic

(1)

Hebei Songchen Pharmaceut

(1)

Hebei University

(1)

Hefei University of Techn

(1)

Hefei Xingyou Optical Tec

(1)

Hefei Yuanzhi Pharmaceuti

(1)

Heilongjiang Dilong Pharm

(1)

Heilongjiang Jiren Pharma

(1)

Heilongjiang University o

(1)

Heilongjiang University o

(1)

Hejing Medical Tech Shang

(1)

Henan Baihuikang Biotechn

(1)

Henan Jingdong Xijian Pha

(1)

Henan Jishi Pharmaceutica

(1)

Henan Tanatu Ind Co Ltd

(1)

Henan Tiefu Medical Tech

(1)

Henan University of Chine

(1)

Henan University of Techn

(1)

Henan Xiangyu Medical Equ

(1)

Henan Yinghua Biotechnolo

(1)

Henan Yuchen Pharmaceutic

(1)

Hepu Shengyi Medical Tech

(1)

Hoffmann La Roche [ch]; R

(1)

Hoffmann La Roche [ch]; R

(1)

Hoffmann La Roche [ch]; R

(1)

Hoffmann La Roche; Klinik

(1)

Hoffmann La Roche; Roche

(1)

Homo Contribuens Res And

(1)

Hong Kong Polytechnic Uni

(1)

HotSpot Therapeutics

(1)

(1)

(1)

Huaiyin Institute of Tech

(1)

Huaji Medical Tech Beijin

(1)

Huana Global Biotech Co L

(1)

Huashang Gongke Tianjin E

(1)

Huayi Pharmaceutical Anhu

(1)

Huazhong University of Sc

(1)

Huazhong University of Sc

(1)

Hubei Danao Pharmaceutica

(1)

Hubei Guangchen Pharmaceu

(1)

Hubei Guangren Medicament

(1)

Hubei Jiangxia Laboratory

(1)

Hubei Lishizhen Tradition

(1)

Hubei Minsheng Biopharmac

(1)

Hubei Provincial Bafeng P

(1)

Hubei Shengtong Rongzhi T

(1)

Hubei Shuangxing Pharmace

(1)

Hubei University of Medic

(1)

Hubei University of Scien

(1)

Hubei University of Scien

(1)

Hubei Zhonglian Tech Co L

(1)

Huisheng Biological Pharm

(1)

Huizhou Zhongli Pharmaceu

(1)

Hunan Agricultural Univer

(1)

Hunan Anxiang Zhengyang H

(1)

Hunan Dongting Pharmaceut

(1)

Hunan Jiudian Hongyang Ph

(1)

Hunan Lisai Pharmaceutica

(1)

Hunan Nutrition Tree Biot

(1)

Hunan Paigelan Pharmaceut

(1)

Hunan Qingjing Biological

(1)

Hunan Sailong Pharmaceuti

(1)

Hunan University of Chine

(1)

Hunan University of Chine

(1)

Hunan Xuxiang Biological

(1)

Hunan Zhengzhong Pharmace

(1)

Huzhou Guliheng New Mater

(1)

Icahn School of Medicine,

(1)

Il Yang Pharm Co Ltd

(1)

Ilko Ilac Sanayi Ve Ticar

(1)

Immuneonco Biopharmaceuti

(1)

Impulse Pharmaceuticals L

(1)

Imworks Pty Ltd

(1)

Industry Univ Cooperation

(1)

Inmedical Therapeutics S

(1)

Inner Mongolia Autonomous

(1)

Inner Mongolia Xihuangtan

(1)

Innovative Molecules Gmbh

(1)

Innovo Therapeutics

(1)

Insilico Medicine

(1)

Inst Med Biotechnology Ca

(1)

Inst Nat Sante Rech Med [

(1)

Inst Nat Sante Rech Med [

(1)

Inst Of Basic Theory For

(1)

Institute of Basic Medica

(1)

Institute of Urban Enviro

(1)

Institute of Zoology, Chi

(1)

Interius Biotherapeutics

(1)

Invaryant Health Llc

(1)

Invea Therapeutics Inc [u

(1)

Invia Therapeutics Inc

(1)

Io Therapeutics Inc [us];

(1)

(1)

(1)

Itf Res & Pharma Inc

(1)

Iview Pharmaceuticals Inc

(1)

(1)

Janssen Pharmaceutica

(1)

Janssen Pharmaceuticals

(1)

Jaz Pharma Ireland Ltd; S

(1)

Jazz Pharmaceuticals Rese

(1)

Jb Radiopharmaceuticals H

(1)

Jeil Pharmaceutical Co Lt

(1)

Jiande Huaming Tech Co Lt

(1)

Jiangnan University; Shan

(1)

Jiangsu Aidea Pharmaceuti

(1)

Jiangsu Chia Tai Fenghai

(1)

Jiangsu Chuangshengyuan I

(1)

Jiangsu College of Nursin

(1)

Jiangsu Feiyu Pharmaceuti

(1)

Jiangsu Fubang Pharmaceut

(1)

Jiangsu Gaoke Pharmaceuti

(1)

Jiangsu Hansoh Pharmaceut

(1)

Jiangsu Hansoh Pharmaceut

(1)

Jiangsu Health Vocational

(1)

Jiangsu Hengfeng Pharmace

(1)

Jiangsu Henghong Medical

(1)

Jiangsu Hengrui Medicine;

(1)

Jiangsu Hengrui Pharmaceu

(1)

Jiangsu Huiyou Biotechnol

(1)

Jiangsu Jianjia Pharmaceu

(1)

Jiangsu Jiye Pharmaceutic

(1)

Jiangsu Lianhuan Pharmace

(1)

Jiangsu Libo Pharmaceutic

(1)

Jiangsu Protelight Pharma

(1)

Jiangsu Taosheng Pharmace

(1)

Jiangsu Tuohong Kangheng

(1)

Jiangsu University of Sci

(1)

Jiangsu Wangao Pharmaceut

(1)

Jiangsu Xiansheng Biologi

(1)

Jiangsu Yueshi Pharmaceut

(1)

Jiangsu Zetai Pharmaceuti

(1)

Jiangsu Zhiyuan Pharmaceu

(1)

Jiangsu Zhongyu Pharmaceu

(1)

Jiangxi Bolai Pharmacy Co

(1)

Jiangxi Chengtong Pharmac

(1)

Jiangxi Daoshi Chemical C

(1)

Jiangxi Guangyuan Chemica

(1)

Jiangxi Heying Pharmaceut

(1)

Jiangxi Jinding Pharmaceu

(1)

Jiangxi Jinggangshan Tian

(1)

Jiangxi Pinxin Pharmaceut

(1)

Jiangxi Provincial Hospit

(1)

Jiangxi Prozin Pharmaceut

(1)

Jiateng Intelligent Tech

(1)

Jiaxing Tianhe Pharmaceut

(1)

Jiaxing University

(1)

Jiaxing Xinrui Pharmaceut

(1)

Jiaxing Zhizheng Pharmace

(1)

Jiazhong Medical Tech Gua

(1)

Jilin Hongjiu Biotech Co

(1)

Jilin University

(1)

Jilin University; Beijing

(1)

Jilin University; Inst Of

(1)

Jinan Dasen Refrigeration

(1)

Jinan University

(1)

Jinchuan Group Nickel & C

(1)

Jinghua Pharmaceutical Ch

(1)

Jinhe Bio Tech Co Ltd

(1)

Jining Huaneng Pharmaceut

(1)

Jining University

(1)

Jinpai Chizhengtang Pharm

(1)

Jinxi Spring Pharmaceutic

(1)

Jitai Biotech Inc; Guangd

(1)

Jiujiang Defu New Energy

(1)

Jiyinmei Pharmaceutical G

(1)

Jumbo Drug Bank

(1)

Jumpcan Pharmaceutical Gr

(1)

Jutian Wisdom Shenzhen Co

(1)

K36 Therapeutics

(1)

(1)

Kangbaida (Sichuan) Biote

(1)

Kangbaida Sichuan Biomedi

(1)

Kanglong Huacheng Chiral

(1)

Karuna Therapeutics Ltd

(1)

Kepu Pharmaceutical Shand

(1)

Kewei Ningbo Machinery Mf

(1)

Keyherblab Co Ltd

(1)

Kinaset Therapeutics Inc

(1)

Kindeva Drug Delivery

(1)

Kingdomway Biotech Jiangs

(1)

(1)

Kobayashi Pharmaceutical

(1)

Kolinpharma S P A

(1)

Korea University Research

(1)

Kudo Pharmaceutical Guang

(1)

Kunming Atom High Tech Ph

(1)

Kunming Longjin Pharmaceu

(1)

(1)

Kyoto University

(1)

(1)

Kyowa Pharma Chemical Co

(1)

Kyungpook Nat Univ Ind Ac

(1)

(1)

Laikai Pharmaceutical Nin

(1)

Lantern Pharma Inc

(1)

Lantheus Medical Imaging

(1)

Lanzhou Baiyuan Gene Tech

(1)

Lanzhou University

(1)

Lanzhou University Second

(1)

Laurent Pharmaceuticals I

(1)

Layers Cosmetic Co Ltd

(1)

Lebi Guangzhou Health Ind

(1)

(1)

(1)

Lianyungang Kaifeng Bio M

(1)

Liaoning Herbapex Pharmac

(1)

Liaoning Minkang Pharmace

(1)

Liaoning Zhongjian Pharma

(1)

Ligand Pharmaceuticals In

(1)

(1)

(1)

(1)

Liuzhou City Healthcare H

(1)

Livzon Group Fuzhou Fuxin

(1)

Livzon Pharmaceutical Gro

(1)

Loewenstein Medical Techn

(1)

Longyan People\'s Hospita

(1)

Lufeng Meikang Biotechnol

(1)

Luoyang Polytechnic

(1)

Luoyang Xunluo Medical Te

(1)

Luwan Branch Rui Jin Hosp

(1)

Lys Therapeutics

(1)

Mabwell Therapeutics Inc

(1)

MapLight Therapeutics

(1)

Massachusetts Gen Hospita

(1)

Mat Nv [be]; Fluidda Nv

(1)

Mayinglong Pharmaceutical

(1)

Mederis Diabetes Llc

(1)

Medisca Pharmaceutique

(1)

Medivation Prostate Thera

(1)

Megafine Pharma P Ltd

(1)

Meis Tech Co Ltd [jp]; Bi

(1)

Meiya Pharmaceutical Haia

(1)

Memorial Sloan Kettering

(1)

Merck Sharp & Dohme Llc [

(1)

Merida Biosciences Inc

(1)

Meta Pharm Co Ltd

(1)

Mianyang Central Hospital

(1)

Minghui Pharmaceutical Ha

(1)

Minovia Therapeutics

(1)

Minxian Jinkang Tradition

(1)

(1)

Mirati Therapeutics

(1)

Mitsubishi Tanabe Pharma

(1)

Modulation Therapeutics I

(1)

Moore Terry William Burto

(1)

Mwenger Therapeutics Inc

(1)

(1)

Nanchang Helioeast Scienc

(1)

Nanchang University; Shen

(1)

Nanfang Hospital, Souther

(1)

Nanjing Atom High Tech Ph

(1)

Nanjing Do Gene Medical T

(1)

Nanjing Jiuhu Gufang Trad

(1)

Nanjing Juhetai Biotechno

(1)

Nanjing University

(1)

Nanjing University of Chi

(1)

Nanjing Zhihe Pharmaceuti

(1)

Nankai University

(1)

Nanoprecision Medical Inc

(1)

Nantong Cawiheal Medical

(1)

Nantong Hospital of Tradi

(1)

Nanyang Pukang Hengwang M

(1)

Nanyang Technological Uni

(1)

Nastech Pharmaceutical Co

(1)

Nat Center Neurology & Ps

(1)

Nb Health Laboratory Co L

(1)

(1)

Nested Therapeutics Inc

(1)

(1)

Neurim Pharmaceuticals 19

(1)

NeuroDawn Pharmaceutical

(1)

Neurocrine Biosciences; N

(1)

Neurostrix Pharmaceutical

(1)

Newave Pharmaceutical

(1)

Ninebiopharm Co Ltd

(1)

Ningbo No 2 Hospital

(1)

Ningbo Yihe Medical Equip

(1)

Ningbo Yihe Medical Equip

(1)

Ningxia Medical Universit

(1)

Ningxia Qifuyuan Pharmace

(1)

Ningxia Taisheng Biotechn

(1)

Ningxia Taiyicin Biotech

(1)

Ningxia University

(1)

Niumai Biotechnology Suzh

(1)

Nkd Pharma Co Ltd

(1)

No 3 Eng Co Ltd Cccc Firs

(1)

Nobel Pharma Co Ltd

(1)

Nodus Oncology Ltd

(1)

(1)

North University of China

(1)

Northern Tech Internation

(1)

Novartis; University Leuv

(1)

Nxera Pharma UK

(1)

OMRON Tateisi Electronics

(1)

ORIC Pharmaceuticals

(1)

OSE Immunotherapeutics

(1)

Ocean University China

(1)

Olatec Therapeutics Inc

(1)

(1)

(1)

(1)

Orisomes Biothech Co Ltd

(1)

Otsuka America Pharmaceut

(1)

Otsuka Pharma Co Ltd [jp]

(1)

Otsuka Prec Health Inc [u

(1)

Oxford University Innovat

(1)

(1)

P Sivarajakumar

(1)

Pacific Marine Biotech Ll

(1)

(1)

Parker Therapeutics Usa I

(1)

Pds Biotechnology Corp

(1)

Peking University People\

(1)

Peking University People\

(1)

Peking University Shenzhe

(1)

(1)

People\'s Hospital of Tan

(1)

Peoples Hospital Of Wuhan

(1)

Peracchi Edson Luiz

(1)

Perfetti Van Melle S P A

(1)

Petignovo Biopharma Inc

(1)

Phaeno Therapeutics Co Lt

(1)

Pharma Res Bio Co Ltd

(1)

(1)

Pharmosa Biopharm Inc

(1)

(1)

Piaoqishi Biotechnology C

(1)

Pingdingshan University

(1)

Pivot Therapeutics Inc

(1)

Polykleitos Pharmaceutica

(1)

Portal Therapeutics Inc

(1)

Posida Therapeutics Inc

(1)

Powerchina Zhongnan Engin

(1)

(1)

Precogify Pharmaceutical

(1)

Prezer Therapeutics Inc

(1)

Prilenia Therapeutics Inc

(1)

Prime Gene Therapeutics

(1)

Principia Biopharma

(1)

Proqr Therapeutics Ii Bv

(1)

(1)

Purdue Research Foundatio

(1)

Purspec Tech Inc; Qingpu

(1)

Puruo Traditional Chinese

(1)

(1)

Qilu Animal Health Produc

(1)

Qilu University of Techno

(1)

Qilu University of Techno

(1)

Qingdao Liteng Medicine T

(1)

Qingdao Municipal Hospita

(1)

Qingdao No Antibiotics Bi

(1)

Qingdao Ruiside Medical L

(1)

Qingdao University

(1)

Qinghai Pharmaceutical Co

(1)

Qinghai Salt Lake Industr

(1)

Qionghai People\'s Hospit

(1)

Quanta Matrix Inc

(1)

Quell Therapeutics

(1)

RaQualia Pharma

(1)

Radar Therapeutics Inc

(1)

Rambam Med Tech Ltd [il];

(1)

(1)

Relay Therapeutics

(1)

Renji Hospital Shanghai J

(1)

Renji Hospital Shanghai J

(1)

Research Center for Eco-E

(1)

Resolution Therapeutics

(1)

Restoration Therapeutics

(1)

Retex Pharmaceuticals Inc

(1)

Revolution Medicines

(1)

Risen Suzhou Pharma Tech

(1)

Roche Sequencing Solution

(1)

Rona Bioscience Ltd [hk];

(1)

Rongchang Pharmaceuticals

(1)

Rongkang Group Guangxi Ka

(1)

Rontis Hellas S A [gr]; P

(1)

Ruijin Hospital Shanghai

(1)

SK Biopharmaceuticals

(1)

SPR Therapeutics

(1)

Sail Biomedicines

(1)

Samjin Pharm Co Ltd

(1)

Samyang Holdings

(1)

(1)

Sanofi Biotechnology [fr]

(1)

Sanya Mingyao Germplasm I

(1)

Sanya Traditional Chinese

(1)

(1)

(1)

Scherer Technologies Llc

(1)

Sciwind Biosciences Usa C

(1)

Scohia Pharma Inc

(1)

Secarna Pharmaceuticals G

(1)

Second Military Medical U

(1)

Selva Therapeutics Inc

(1)

Sensorium Therapeutics

(1)

Shaanxi Ark Pharmaceutica

(1)

Shaanxi Hanjiang Pharmace

(1)

Shaanxi Micot Pharmaceuti

(1)

Shaanxi Shengji Kangze Tr

(1)

Shaanxi University of Chi

(1)

Shandong Baifu Freda Phar

(1)

Shandong Dayu Animal Phar

(1)

Shandong Dehao Chemical C

(1)

Shandong E Fine Pharmacy

(1)

Shandong Haihua Co Ltd; T

(1)

Shandong Jincheng Courage

(1)

Shandong Jincheng Pharmac

(1)

Shandong Jiuzhitang Pharm

(1)

Shandong Liaocheng Huayan

(1)

Shandong Lingkai Pharmace

(1)

Shandong New Time Pharmac

(1)

Shandong Runjun Pharmaceu

(1)

Shandong SMA Pharmatech

(1)

Shandong Simcere Biologic

(1)

Shandong WEGO Prefills Ph

(1)

Shandong Wanbang Sainuoka

(1)

Shandong Xinda Gene Tech

(1)

Shandong Xinhua Pharmaceu

(1)

Shandong Xinrenhe Printin

(1)

Country

X

China Patent News

WIPO Patent News

European Patent News

Status

X

1 - 100 of 1845 Items

Sign In / Subscribe

Select All

Share
Download as Excel
Download as PDF

Bridgebio Gene Therapy LLC Submits United States Patent Application for Methods and Compositions for Treating Leukodystrophies

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Bridgebio Gene Therapy LLC has submitted a patent application for Methods and Compositions for Treating Leukodystrophies. This invention was developed by Laforet Genevieve, Shaywitz Adam and Kirby Kathleen M. The patent application number is US202218700508 20221012. The patent publication number is US20..

Kwiecien Jacek Submits United States Patent Application for Treatment of Neuroinflammation

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Kwiecien Jacek has submitted a patent application for Treatment of Neuroinflammation. The patent application number is US202418805174 20240814. The patent publication number is US20260048095 (A1). International Patent Classification codes are A61K31/121, A61K36/899, A61K38/16, A61P25/00 and A61P29/00...

Yuyama Manufacturing Submits United States Patent Application for Drug-mixing System and Program

Pharmaceutical

| Mon 23 Feb 2026

Alexandria, Feb. 23 -- Yuyama Manufacturing has submitted a patent application for Drug-mixing System and Program. This invention was developed by Nishida Junichiro and Kitagawa Junya. The patent application number is US202519367818 20251024. The patent publication number is US20260047981 (A1). International Patent Classifica..

Electric Power Research Institute China Southern Power Grid and Tianjin University Seek Patent for Converter Station Parameter Determination Method and Device for Improving Transie..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Electric Power Research Institute China Southern Power Grid and Tianjin University have sought patent for Converter Station Parameter Determination Method and Device for Improving Transient Voltage Stability. This invention was developed by Li Qing, Wang Liping, Chen Peiyuan, Liao Xiupu, Xu Zhihua, Wu Mao, Ma..

Renji Hospital Shanghai Jiao Tong University School of Medicine and Health Cloud Shanghai Digital Tech Co Ltd Submit Patent Application for Internet Hospital Expert Registration Ad..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Renji Hospital Shanghai Jiao Tong University School of Medicine and Health Cloud Shanghai Digital Tech Co Ltd have submitted a patent application for Internet Hospital Expert Registration Adaptation System Based on Artificial Intelligence Driving. Wang Chunming, Zhou Ying, Pan Zheng, Li Xuewei, Xu Di, Wu Jun,..

Ningbo Yihe Medical Equipment Co Ltd and Suzhou Yihe Pharmaceutical Co Ltd Seek Patent for Intelligent Monitoring Device and Method for Inhaler Based on Audio Signals

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Ningbo Yihe Medical Equipment Co Ltd and Suzhou Yihe Pharmaceutical Co Ltd have sought patent for Intelligent Monitoring Device and Method for Inhaler Based on Audio Signals. This invention was developed by Fan Ziyi, Zhu Jingxu, Ye Yuqing, Ma Yingliang, Dong Jie, Liu Ke and Shi Kaiqi. The patent applicatio..

Dandong Xin Shi Dai Biotech Pharmaceuticals Co Ltd and Liaoning Xinshidai Biomedical Industry Tech Research Co Ltd Submit Patent Application for Vacuum Paste Making Machine and Aux..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Dandong Xin Shi Dai Biotech Pharmaceuticals Co Ltd and Liaoning Xinshidai Biomedical Industry Tech Research Co Ltd have submitted a patent application for Vacuum Paste Making Machine and Auxiliary Mechanism Thereof. Xu Bing, Liu Chunyan, Yan Meiling, Sun Tianlang and He Lijuan developed the invention. The ..

China Union Chempharma Suzhou Co Ltd and Suzhou No. 3 Pharmaceutical Factory Co Ltd Submit Chinese Patent Application for Impurity Precipitation and Separation Device Based on Drug..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 --China Union Chempharma Suzhou Co Ltd and Suzhou No. 3 Pharmaceutical Factory Co Ltd have submitted a patent application for Impurity Precipitation and Separation Device Based on Drug Preparation. This invention was developed by Huang Junhao, Zhang Bo and Chen Lei. The patent application number is CN20251112..

Hangzhou Yisikang Pharmaceutical Tech Co Ltd and Zhejiang Hongsheng Biotechnology Apply for Patent on Porcine Bacterial Polysaccharide-viral Protein Conjugate Vaccine as Well as Pr..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Hangzhou Yisikang Pharmaceutical Tech Co Ltd and Zhejiang Hongsheng Biotechnology have applied Chinese patent for Porcine Bacterial Polysaccharide-viral Protein Conjugate Vaccine as Well as Preparation Method and Application Thereof. Chai Wenqin, Wu Chao, Shu Jianhong, He Yulong, Zha Yinhe, Shen Ruifang, Wang..

Liaoning Herbapex Pharmaceutical Group Co Ltd and Liaoning Shangyao Tech Development Co Ltd Apply for Patent on Nerve-stabilizing Composition, Preparation Method, Preparation and Q..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Liaoning Herbapex Pharmaceutical Group Co Ltd and Liaoning Shangyao Tech Development Co Ltd have applied Chinese patent for Nerve-stabilizing Composition, Preparation Method, Preparation and Quality Control and Content Determination Method Thereof. Guo Zhenwu, Yu Xuefeng, Zhang Yafeng, Shi Huiyang, Zhang Chus..

Zhongshan People's Hospital and Guangdong Pharmaceutical University Submit Chinese Patent Application for Morinda Officinalis-inulin Composition and Application Thereof in Renal Fi..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Zhongshan People's Hospital and Guangdong Pharmaceutical University have submitted a patent application for Morinda Officinalis-inulin Composition and Application Thereof in Renal Fibrosis Products. This invention was developed by Zhao Weiguo, Xiao Wei, Chen Ali, Chen Kun, Li Zhuoya and Xin Ling. The paten..

Changzhou STA Pharmaceutical and Shanghai Syntheall Pharmaceuticals Res File Chinese Patent Application for Application of Amide Hydrolase in Preparation of Chiral Amines

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Changzhou STA Pharmaceutical and Shanghai Syntheall Pharmaceuticals Res have filed a patent application for Application of Amide Hydrolase in Preparation of Chiral Amines. This invention was developed by Chang Yaowen, Li Jie, Huang Jiao, Li Tingting and Dong He. The patent application number is CN202410262..

China State Institute Of Pharmaceutical Industry Co Ltd and Shanghai Institute Of Pharmaceutical Industry Co Ltd Submit Patent Application for Epidermal Skin Model and Constructio..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- China State Institute Of Pharmaceutical Industry Co Ltd and Shanghai Institute Of Pharmaceutical Industry Co Ltd have submitted a patent application for Epidermal Skin Model and Construction Method and Application Thereof. Liu Li, Deng Wenchang, Xie Xiaorui, Cai Huimin and Tang Junjie developed the invention...

Shandong University of Technology and Shandong Jincheng Bio Pharmaceutical Co Ltd Submit Chinese Patent Application for Engineering Modified Bacillus Subtilis as Well as Preparatio..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Shandong University of Technology and Shandong Jincheng Bio Pharmaceutical Co Ltd have submitted a patent application for Engineering Modified Bacillus Subtilis as Well as Preparation Method and Application Thereof. This invention was developed by Gao Xiuzhen, Ma Qinyuan, Yang Shaomei, Wang Hui, Feng Xu, Fu S..

Tianjin University of Science & Technology and Tianjin Yuanhui Tech Co Ltd Seek Patent for Propionibacterium Jensenii Bred Through Aerospace Superposition Chemical Mutation and Met..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Tianjin University of Science & Technology and Tianjin Yuanhui Tech Co Ltd have sought patent for Propionibacterium Jensenii Bred Through Aerospace Superposition Chemical Mutation and Method for Mutagenizing, Screening and Fermenting Propionic Acid by Propionibacterium Jensenii. This invention was developed b..

Yantai Institute Coastal Zone Research, CAS and Shandong Yinuokang Pharmaceutical Co Ltd Submit Chinese Patent Application for Chitosan Quaternary Ammonium Salt Derivative Containi..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Yantai Institute Coastal Zone Research, CAS and Shandong Yinuokang Pharmaceutical Co Ltd have submitted a patent application for Chitosan Quaternary Ammonium Salt Derivative Containing Selenium Cyano Group as Well as Preparation Method and Application of Chitosan Quaternary Ammonium Salt Derivative. This inve..

Hangzhou Yisikang Pharmaceutical Tech Co Ltd and Zhejiang Hongsheng Biotechnology Submit Patent Application for Extraction and Purification Method Suitable for Swine-derived Bacter..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Hangzhou Yisikang Pharmaceutical Tech Co Ltd and Zhejiang Hongsheng Biotechnology have submitted a patent application for Extraction and Purification Method Suitable for Swine-derived Bacterium Capsular Polysaccharide. Chai Wenqin, Zong Chengli, Wu Chao, Shen Ruifang, Li Man, Wang Jianguo, Tong Xiaxia and Xu ..

Shanghai Institute Of Pharmaceutical Industry Co Ltd and China State Inst Of Pharmaceutical Industry Co Ltd Submit Chinese Patent Application for Anti-human Delta-like4 Antibody as..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Shanghai Institute Of Pharmaceutical Industry Co Ltd and China State Inst Of Pharmaceutical Industry Co Ltd have submitted a patent application for Anti-human Delta-like4 Antibody as Well as Preparation and Application Thereof. This invention was developed by Xie Liping, Wang Ziyu, Zhuang Weiliang, Zhang Wei ..

Tianjin University and Qinghai Provincial Drug Inspection and Testing Institute File Chinese Patent Application for Phenylpropanoid Glycoside with Antioxidant Activity as Well as E..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Tianjin University and Qinghai Provincial Drug Inspection and Testing Institute have filed a patent application for Phenylpropanoid Glycoside with Antioxidant Activity as Well as Extraction and Separation Method and Application Thereof. This invention was developed by Su Yanfang, Zhu Fuhua, Zhang Wei, Zheng Y..

Suzhou Zelgen Biopharmaceutical Co Ltd and Shanghai Zejing Medical Tech Co Ltd Seek Patent for Amino-substituted Aromatic Heterocycle Inhibitor as Well as Preparation Method and Ap..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Suzhou Zelgen Biopharmaceutical Co Ltd and Shanghai Zejing Medical Tech Co Ltd have sought patent for Amino-substituted Aromatic Heterocycle Inhibitor as Well as Preparation Method and Application Thereof. This invention was developed by Lyu Binhua, Cui Dawei and Liu Lianjun. The patent application number ..

Jiangsu Hansoh Pharmaceutical Group and Shanghai Hansoh Biomedical Submit Patent Application for Heterocyclic Carbonyl Derivative Regulator as Well as Preparation Method and Applic..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Jiangsu Hansoh Pharmaceutical Group and Shanghai Hansoh Biomedical have submitted a patent application for Heterocyclic Carbonyl Derivative Regulator as Well as Preparation Method and Application Thereof. Xiao Hualing, Wu Guolin, Xing Jing, Deng Haining and Liu Yong developed the invention. The patent appl..

Shenyang Pharmaceutical University and 3D Biooptima Co Ltd Seek Patent for 2, 4-diaminopyrimidine Compound and Application Thereof

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Shenyang Pharmaceutical University and 3D Biooptima Co Ltd have sought patent for 2, 4-diaminopyrimidine Compound and Application Thereof. This invention was developed by Zhao Yanfang, Hou Yunlei, Fu Siyu, Wei Jiakuan, Li Chunting, Tong Xiaoyan, Nishi Harukuni, Shi Xuan and Tong Minghui. The patent applica..

Shanghai Jiao Tong University and Guangdong OPPO Mobile Telecommunications Submit Chinese Patent Application for Decoding Method, Decoder and Storage Medium

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Shanghai Jiao Tong University and Guangdong OPPO Mobile Telecommunications have submitted a patent application for Decoding Method, Decoder and Storage Medium. This invention was developed by Xu Yiling, Gao Linyao and Wei Honglian. The patent application number is CN20238092043 20230227. The patent publica..

Jiangsu Hengrui Medicine and Shanghai Shengdi Pharmaceutical Co Ltd File Chinese Patent Application for IL-36R Binding Protein and Medical Application Thereof

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Jiangsu Hengrui Medicine and Shanghai Shengdi Pharmaceutical Co Ltd have filed a patent application for IL-36R Binding Protein and Medical Application Thereof. This invention was developed by Run Changqing, Su Lu, Cui Xueqin, Lin Yuan, Lin Kan and Liao Cheng. The patent application number is CN20248008757 ..

Bailite Biopharmaceutical Co Ltd and Hangzhou Bailite Biological Pharmaceutical Co Ltd Seek Patent for Anti-HER2/trop2 Antibodies and Uses Thereof

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Bailite Biopharmaceutical Co Ltd and Hangzhou Bailite Biological Pharmaceutical Co Ltd have sought patent for Anti-HER2/trop2 Antibodies and Uses Thereof. This invention was developed by Yang Ming and Zhong Hongyan. The patent application number is CN20238081040 20231130. The patent publication number is C..

Hangzhou Innogate Pharma and Hangzhou Yingrui Biological Medicine Co Ltd File Chinese Patent Application for Compounds as USP1 Inhibitors

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Hangzhou Innogate Pharma and Hangzhou Yingrui Biological Medicine Co Ltd have filed a patent application for Compounds as USP1 Inhibitors. This invention was developed by Zhang Hancheng, Cai Congcong and Zhu Shiya. The patent application number is CN20248008514 20240122. The patent publication number is CN..

Arvinas Operations and Pfizer File Chinese Patent Application for Methods of Treating Breast Cancer

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Arvinas Operations and Pfizer have filed a patent application for Methods of Treating Breast Cancer. This invention was developed by Pike Robert, Yang David Z and Tan Weiwei. The patent application number is CN20238092547 20231201. The patent publication number is CN120603593 (A). International Patent Clas..

Yin Yong and Zhou Yuan Seek Patent for Antibody-based Molecule or Complex, Expression System and Pharmaceutical Composition Thereof, and Methods Thereof

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Yin Yong and Zhou Yuan have sought patent for Antibody-based Molecule or Complex, Expression System and Pharmaceutical Composition Thereof, and Methods Thereof. The patent application number is US202418808060 20240818. The patent publication number is US20260049133 (A1). International Patent Classifica..

Kanglong Huacheng Chiral Pharmaceutical Tech Ningbo Co Ltd Submits Chinese Patent Application for Preparation Method of (4, 4-difluorotetrahydrofuran-3-yl) Methanol

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Kanglong Huacheng Chiral Pharmaceutical Tech Ningbo Co Ltd has submitted a patent application for Preparation Method of (4, 4-difluorotetrahydrofuran-3-yl) Methanol. This invention was developed by Wu Xiaoyu, Zhao Xin, Ruan Weijie, An Gang and Fang Kai. The patent application number is CN202510747420 20250..

Sichuan Haoyun Pharmaceutical Co Ltd Files Chinese Patent Application for Method for Purifying and Separating Acipimox

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Sichuan Haoyun Pharmaceutical Co Ltd has filed a patent application for Method for Purifying and Separating Acipimox. This invention was developed by Zhang Hongkun, Teng Degang, Naka Yusei and Xiong Shiping. The patent application number is CN202510790765 20250613. The patent publication number is CN120607..

Bide Pharmatech Co Ltd Submits Chinese Patent Application for Synthesis Method of 1h-indazole-7-tert-butyl Formate

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Bide Pharmatech Co Ltd has submitted a patent application for Synthesis Method of 1h-indazole-7-tert-butyl Formate. This invention was developed by Zhang Ruihao, Lee Seung Taek, Tan Junde, Ni Qiang and Guo Xiaoyan. The patent application number is CN202510699291 20250528. The patent publication number is C..

Shanxi Guorun Pharmaceutical Co Ltd Submits Chinese Patent Application for Preparation Method of Phenazopyridine Hydrochloride and Phenazopyridine Hydrochloride Capsule Preparation

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Shanxi Guorun Pharmaceutical Co Ltd has submitted a patent application for Preparation Method of Phenazopyridine Hydrochloride and Phenazopyridine Hydrochloride Capsule Preparation. This invention was developed by Yang Yuping. The patent application number is CN202510689394 20250527. The patent publication..

Impulse Pharmaceuticals LLC Submits United States Patent Application for Bite Block

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Impulse Pharmaceuticals LLC has submitted a patent application for Bite Block. This invention was developed by Bryson Ethan Oliver. The patent application number is US202519296348 20250811. The patent publication number is US20260048219 (A1). International Patent Classification codes are A61M16/04 and A..

Atoms For Cure GmbH Files United States Patent Application for Fap-targeting Pharmaceutical Product for Therapy and Diagnosis of Cancers

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Atoms For Cure GmbH has filed a patent application for Fap-targeting Pharmaceutical Product for Therapy and Diagnosis of Cancers. This invention was developed by Rösch Frank and Martin Marcel. The patent application number is US202218721573 20221220. The patent publication number is US20260048156 (A1)...

U.S. Patent and Trademark Office Releases Ardeagen Corp Patent Application for Anti-mesothelin Antibody Conjugates and Methods of Use Thereof

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- U.S. Patent and Trademark Office has released Ardeagen Corp patent application for Anti-mesothelin Antibody Conjugates and Methods of Use Thereof. This invention was developed by Smith Maria Leia, Sutherland May Kung, Hu Yaohua, Wang Xia, Nie Siwei and Gu Jijie. The patent application number is US202519..

U.S. Patent and Trademark Office Releases Risen Suzhou Pharma Tech Co Ltd and Risen Shanghai Pharma Eng Co Ltd Patent Application for Bifunctional Compounds and Uses Thereof

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- U.S. Patent and Trademark Office has released Risen Suzhou Pharma Tech Co Ltd and Risen Shanghai Pharma Eng Co Ltd patent application for Bifunctional Compounds and Uses Thereof. This invention was developed by Lu Jiasheng, Ji Xiang, Du Kang, Zhang Qiguo, Wu Gang, He Xiaolin, Wu Yanpeng, Zong Bin, Zhou Tia..

U.S. Patent and Trademark Office Receives Center for Neuromusculoskeletal Restorative Medicine Ltd Patent Application for Self-therapeutic Drug Delivery System for Neurodegenerativ..

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- U.S. Patent and Trademark Office has received Center for Neuromusculoskeletal Restorative Medicine Ltd patent application for Self-therapeutic Drug Delivery System for Neurodegenerative Diseases. Choi Chung Hang Jonathan, Chan Ho Yin Edwin and Lee Kit Cheung developed the invention. The patent applicati..

Guangzhou Yipu Biotechnology Co Ltd Seeks Patent for Collagen Peptide Composition as Well as Effect and Application Thereof in Improving Immunity

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Guangzhou Yipu Biotechnology Co Ltd has sought patent for Collagen Peptide Composition as Well as Effect and Application Thereof in Improving Immunity. This invention was developed by Jiang Ronggan, Ma Yingying and Li Xiaoli. The patent application number is CN202510758245 20250609. The patent publication ..

Jiangsu Tuohong Kangheng Pharmaceutical Co Ltd Submits Chinese Patent Application for GD2 CAR-T Cell Co-expressing IL-15 and PD-1 Antibodies and Application of GD2 CAR-T Cell

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Jiangsu Tuohong Kangheng Pharmaceutical Co Ltd has submitted a patent application for GD2 CAR-T Cell Co-expressing IL-15 and PD-1 Antibodies and Application of GD2 CAR-T Cell. This invention was developed by Li Jun, Liao Lianming and Huang Tongge. The patent application number is CN202510682842 20250526. T..

Immuneonco Biopharmaceuticals Shanghai Co Ltd Files Chinese Patent Application for Recombinant Fusion Proteins Targeting Cd38 and Cd47

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Immuneonco Biopharmaceuticals Shanghai Co Ltd has filed a patent application for Recombinant Fusion Proteins Targeting Cd38 and Cd47. This invention was developed by Tian Wenzhi, Li Song, Chen Dianze, Yang Yanan and Guo Huiqin. The patent application number is CN202410258294 20240307. The patent publicatio..

State Intellectual Property Office of China Releases Zhejiang University and Zhejiang Univ Intelligent Innovation Drug Research Institute Patent Application for Novel Coronavirus N..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- State Intellectual Property Office of China has released Zhejiang University and Zhejiang Univ Intelligent Innovation Drug Research Institute patent application for Novel Coronavirus Neutralizing Antibody Variant and Application Thereof. This invention was developed by Zhou Zhan, Li Xiufeng, Zhao Wenbin, Chen..

Suzhou Xingzhou Biotechnology Co Ltd Seeks Patent for Targeted Human Sstr2 Polypeptide Analogue, Coupling Medicine Thereof, Preparation Method and Application

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Suzhou Xingzhou Biotechnology Co Ltd has sought patent for Targeted Human Sstr2 Polypeptide Analogue, Coupling Medicine Thereof, Preparation Method and Application. This invention was developed by Lyu Pei, Tian Changlin and Zhang Mengge. The patent application number is CN202410254515 20240306. The patent ..

Beijing Normal University Applies for Patent on Amino Adipic Acid-urea Derivative Containing L-proline and Application Thereof

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Beijing Normal University has applied Chinese patent for Amino Adipic Acid-urea Derivative Containing L-proline and Application Thereof. Zhang Junbo, Li Zuojie, Han Peiwen and Diao Lina developed it. The patent application number is CN202510746866 20250605. The patent publication number is CN120607580 (A)...

Guizhou University Files Chinese Patent Application for Purine Nucleoside Compound Containing 1, 3, 4-oxadiazole Structure as Well as Preparation Method and Application of Purine N..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Guizhou University has filed a patent application for Purine Nucleoside Compound Containing 1, 3, 4-oxadiazole Structure as Well as Preparation Method and Application of Purine Nucleoside Compound. This invention was developed by Yang Song, Cheng Long, Huang Yanwei, Luo Rongshuang, Zheng Yuwen, Shao Wubin, Zh..

Anhui Ruibai Pharmaceutical Co Ltd Seeks Patent for Preparation Method and Application of Tlr9 Targeted Cpg Oligonucleotide Adjuvant

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Anhui Ruibai Pharmaceutical Co Ltd has sought patent for Preparation Method and Application of Tlr9 Targeted Cpg Oligonucleotide Adjuvant. This invention was developed by Liu Zhubing, Liu Qi, Wang Cheng, Zhou Bin, Wang Chuqiao and Gong Lingzhi. The patent application number is CN202510739497 20250604. The ..

Hejing Medical Tech Shanghai Co Ltd Files Chinese Patent Application for Tri-fused Ring Compound as Well as Pharmaceutical Composition and Application Thereof

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Hejing Medical Tech Shanghai Co Ltd has filed a patent application for Tri-fused Ring Compound as Well as Pharmaceutical Composition and Application Thereof. This invention was developed by Xun Guoliang, Xi Jianbei, Liu Yao, Liu Zhi, Chen Jinju, Fang Tao, Zhao Shu, Zhao Cunliang, Chen Yanni, Zhou Yuan, Liang ..

State Intellectual Property Office of China Publishes Guizhou Natural Product Res Center Patent Application for 2-aminopyrimidine Compound, Application Thereof and Antitumor Drug

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- State Intellectual Property Office of China has published Guizhou Natural Product Res Center patent application for 2-aminopyrimidine Compound, Application Thereof and Antitumor Drug. The invention was developed by Yu Gang, Luo Heng, Xu Bixue, Yu Jia, Xu Guangcan, Cheng Sha, Li Huimin, You Chang, Zeng Xiaopin..

State Intellectual Property Office of China Releases Wuhan Jiuzhou Yumin Pharmaceutical Tech Co Ltd Patent Application for Preparation Method of Compound Sabizabulin for Resisting ..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- State Intellectual Property Office of China has released Wuhan Jiuzhou Yumin Pharmaceutical Tech Co Ltd patent application for Preparation Method of Compound Sabizabulin for Resisting Viruses and Tumors. This invention was developed by Fan Zhaoze, Chen Cheng and Chen Long. The patent application number is ..

Haisco Pharmaceutical Group Inc Files Chinese Patent Application for Amidino-containing Heterocyclic Derivative and Application Thereof in Medicine

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Haisco Pharmaceutical Group Inc has filed a patent application for Amidino-containing Heterocyclic Derivative and Application Thereof in Medicine. This invention was developed by Zhang Chen, Lei Ming, Weng Guanglin and Yan Pangke. The patent application number is CN202510247620 20250304. The patent publica..

Shanghai Zhonghua Pharmaceutical Nantong Co Ltd Applies for Patent on Full-automatic Essential Balm Filling Control System Based on PLC Online Monitoring

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Shanghai Zhonghua Pharmaceutical Nantong Co Ltd has applied Chinese patent for Full-automatic Essential Balm Filling Control System Based on PLC Online Monitoring. Zhao Xinjie, Dai Gaofei, Zhao Yongguo and Chen Feixiang developed it. The patent application number is CN202510642166 20250519. The patent publ..

Keyherblab Co Ltd Applies for Patent on Oriental Medicine Diagnosis and Prescription System Based on Artificial Intelligence and Operation Method Thereof

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Keyherblab Co Ltd has applied United States patent for Oriental Medicine Diagnosis and Prescription System Based on Artificial Intelligence and Operation Method Thereof. Roh Euy Joon developed it. The patent application number is US202418912829 20241011. The patent publication number is US20260051402 (A..

Quanta Matrix Inc Submits Chinese Patent Application for Rapid Antibiotic Sensitivity Detection and Identification Method

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Quanta Matrix Inc has submitted a patent application for Rapid Antibiotic Sensitivity Detection and Identification Method. This invention was developed by Kim Tae-hyun, Jiang Junyuan, Lee Ki-yun, Zhang Haixu, Joo Hye-lin, Kim Ha Min, Lim Tae-keun, Kim Dong-yeong and Kwon Sunghoon. The patent application nu..

Mabwell Therapeutics Inc Seeks Patent for Anti-musk Agonistic Antibodies

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Mabwell Therapeutics Inc has sought patent for Anti-musk Agonistic Antibodies. This invention was developed by Wang Yubin, Huang Lei and Du Xin. The patent application number is US202519265808 20250710. The patent publication number is US20260049157 (A1). International Patent Classification codes are A6..

Rna Therapeutics Inc Submits United States Patent Application for Single-chain Ofatumumab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indications

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Rna Therapeutics Inc has submitted a patent application for Single-chain Ofatumumab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indications. This invention was developed by Magoola Matthias and Niazi Sarfaraz K. The patent application number is US202418805506 20240814. The patent publi..

RNA Therapeutics Inc Submits United States Patent Application for Single-chain Ocrelizumab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indications

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- RNA Therapeutics Inc has submitted a patent application for Single-chain Ocrelizumab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indications. This invention was developed by Magoola Matthias and Niazi Sarfaraz K. The patent application number is US202418805486 20240814. The patent publ..

U.S. Patent and Trademark Office Publishes Sanofi Biotechnology and Regeneron Pharmaceuticals Patent Application for Methods for Treating or Preventing Asthma by Administering an I..

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- U.S. Patent and Trademark Office has published Sanofi Biotechnology and Regeneron Pharmaceuticals patent application for Methods for Treating or Preventing Asthma by Administering an IL-4R Antagonist. The invention was developed by Staudinger Heribert, Teper Ariel, Amin Nikhil, Harel Sivan and Graham Neil...

RNA Therapeutics Inc Submits Patent Application for Single-chain Natalizumab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indications

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- RNA Therapeutics Inc has submitted a patent application for Single-chain Natalizumab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indications. Magoola Matthias and Niazi Sarfaraz K developed the invention. The patent application number is US202418803347 20240813. The patent publication ..

Rna Therapeutics Inc Submits United States Patent Application for Single-chain Ranibizumab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indications

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Rna Therapeutics Inc has submitted a patent application for Single-chain Ranibizumab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indications. This invention was developed by Magoola Matthias and Niazi Sarfaraz K. The patent application number is US202418809181 20240819. The patent publ..

RNA Therapeutics Inc Files United States Patent Application for Single-chain Prasinezumab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indications

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- RNA Therapeutics Inc has filed a patent application for Single-chain Prasinezumab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indications. This invention was developed by Magoola Matthias and Niazi Sarfaraz K. The patent application number is US202418807943 20240817. The patent publica..

U.S. Patent and Trademark Office Receives RNA Therapeutics Inc Patent Application for Single-chain Lecanemab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indicatio..

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- U.S. Patent and Trademark Office has received RNA Therapeutics Inc patent application for Single-chain Lecanemab Antibody-transferrin Fusion Protein for Enhanced Efficacy and Indications. Magoola Matthias and Niazi Sarfaraz K developed the invention. The patent application number is US202418803103 20240..

Glytech Inc Applies for Patent on Physiologically-active Peptide Derivative for Treatment of Eye Diseases, Pharmaceutical Composition, Nasal/nasal Drop Preparation, and Use of Phys..

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Glytech Inc has applied United States patent for Physiologically-active Peptide Derivative for Treatment of Eye Diseases, Pharmaceutical Composition, Nasal/nasal Drop Preparation, and Use of Physiologically-active Peptide Derivative. Yamashita Chikamasa developed it. The patent application number is US2..

U.S. Patent and Trademark Office Publishes Cipla Patent Application for an Improved Process for Preparing Antiviral Phosphonate Analogues

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- U.S. Patent and Trademark Office has published Cipla patent application for an Improved Process for Preparing Antiviral Phosphonate Analogues. The invention was developed by Das Arijit and Sawant Ashwini. The patent application number is US202319101615 20230808. The patent publication number is US202600..

Baerenkraft Therapeutics LLC Submits Patent Application for CDK9 Inhibitors

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Baerenkraft Therapeutics LLC has submitted a patent application for CDK9 Inhibitors. Vankayalapati Hariprasad, Li Zhaoliang, Medley Kyle, Yan Dongqing and Bearss David J developed the invention. The patent application number is US202519068991 20250303. The patent publication number is US20260049086 (A1)..

U.S. Patent and Trademark Office Receives Portal Therapeutics Inc Patent Application for Amido Pyrido[3,4-B]indole-1,4-dione Compounds for Treatment of Porphyrias

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- U.S. Patent and Trademark Office has received Portal Therapeutics Inc patent application for Amido Pyrido[3,4-B]indole-1,4-dione Compounds for Treatment of Porphyrias. Bachand Benoit, Huang Edmond, Li Shiguang, Paull Morgan, Browe Kara, Sinha Uma and Zamboni Robert developed the invention. The patent ap..

U.S. Patent and Trademark Office Publishes The Scripps Research Institute Patent Application for Opioid Haptens, Conjugates, Vaccines, and Methods of Generating Antibodies

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- U.S. Patent and Trademark Office has published The Scripps Research Institute patent application for Opioid Haptens, Conjugates, Vaccines, and Methods of Generating Antibodies. The invention was developed by Janda Kim D, Bremer Paul and Natori Yoshihiro. The patent application number is US202519096123 2..

U.S. Patent and Trademark Office Releases Amylyx Pharmaceuticals Inc and The Board of Trustees of the Leland Stanford Junior University Patent Application for GLP-1R Antagonism to ..

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- U.S. Patent and Trademark Office has released Amylyx Pharmaceuticals Inc and The Board of Trustees of the Leland Stanford Junior University patent application for GLP-1R Antagonism to Improve Nutrition Following Gastrointestinal Surgery. This invention was developed by Craig Colleen M and Mclaughlin Tracey..

U.S. Patent and Trademark Office Receives Jaein R&P Inc Patent Application for Combination Therapy of Mixed Herbal Extract and Docetaxel for Preventing or Treating Cancer

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- U.S. Patent and Trademark Office has received Jaein R&P Inc patent application for Combination Therapy of Mixed Herbal Extract and Docetaxel for Preventing or Treating Cancer. Ko Seong Gyu, Choi Yu Jeong, Lee Kangwook, Jeong Miso, Kim Yun-gyeong and Hwang Hyun-ha developed the invention. The patent appl..

Animal Microbiome Analytics Inc Applies for Patent on Products and Methods for Therapeutic Administration of Microorganisms to Non-human Animals

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Animal Microbiome Analytics Inc has applied United States patent for Products and Methods for Therapeutic Administration of Microorganisms to Non-human Animals. Ganz Holly H, Goodman Kari R and Martin Alexandra developed it. The patent application number is US202519366131 20251022. The patent publicatio..

U.S. Patent and Trademark Office Receives Advaccine Suzhou Biopharmaceuticals Co Ltd and Fudan University Patent Application for Combined Treatment Composition for Tumor Treatment ..

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- U.S. Patent and Trademark Office has received Advaccine Suzhou Biopharmaceuticals Co Ltd and Fudan University patent application for Combined Treatment Composition for Tumor Treatment and Combined Treatment Method. Wang Bin, Zhao Gan, Wu Shuting, Zhang Lunan and Kou Zhihua developed the invention. The p..

Nanyang Technological University Submits United States Patent Application for Toll-like Receptor 4 (TLR4) Agonist and Methods of Use Thereof

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Nanyang Technological University has submitted a patent application for Toll-like Receptor 4 (TLR4) Agonist and Methods of Use Thereof. This invention was developed by Qiao Yuan, Li Chenyu and Adamson Christopher William Emmanuel. The patent application number is US202519300420 20250814. The patent publ..

Veralox Therapeutics Inc Submits United States Patent Application for 12-lipoxygenase Inhibitors for the Treatment of Lupus

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Veralox Therapeutics Inc has submitted a patent application for 12-lipoxygenase Inhibitors for the Treatment of Lupus. This invention was developed by Maloney David and Boxer Matthew. The patent application number is US202319128392 20231110. The patent publication number is US20260048071 (A1). Internati..

Wista Laboratories Ltd Submits Patent Application for Treatment of Neurodegenerative Disorders Utilising Methylthioninium (MT)-containing Compounds

Pharmaceutical

| Sun 22 Feb 2026

Alexandria, Feb. 23 -- Wista Laboratories Ltd has submitted a patent application for Treatment of Neurodegenerative Disorders Utilising Methylthioninium (MT)-containing Compounds. Wischik Claude Michel, Storey John Mervyn David and Schelter Björn Olaf developed the invention. The patent application number is US202318869709 2..

Vasopharm GmbH Submits Patent Application for Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions

Pharmaceutical

| Mon 23 Feb 2026

Alexandria, Feb. 23 -- Vasopharm GmbH has submitted a patent application for Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions. Scheurer Peter, Tegtmeier Frank and Schinzel Reinhard developed the invention. The patent application number is US202519369021 20251024. The patent publ..

Turtle Bear Holdings Files United States Patent Application for Tryptamine Compositions for Enhancing Neurite Outgrowth

Pharmaceutical

| Mon 23 Feb 2026

Alexandria, Feb. 23 -- Turtle Bear Holdings has filed a patent application for Tryptamine Compositions for Enhancing Neurite Outgrowth. This invention was developed by Stamets Paul Edward. The patent application number is US202519369146 20251024. The patent publication number is US20260048048 (A1). International Patent Classi..

Jeil Pharmaceutical Co Ltd and Onconic Therapeutics Inc Seeks Patent for Composition for Removing Helicobacter Pylori Comprising Zastaprazan or Pharmaceutically Acceptable Salt The..

Pharmaceutical

| Mon 23 Feb 2026

Alexandria, Feb. 23 -- Jeil Pharmaceutical Co Ltd and Onconic Therapeutics Inc has sought patent for Composition for Removing Helicobacter Pylori Comprising Zastaprazan or Pharmaceutically Acceptable Salt Thereof. This invention was developed by Kim John, Cha Hyun Ju and Han Sang Woo. The patent application number is US202319..

Epitracker Inc Submits United States Patent Application for Fatty Acid Analogs and Their Use in the Treatment of Cognitive Impairment, Behavioral Conditions, and Chronic Pain

Pharmaceutical

| Mon 23 Feb 2026

Alexandria, Feb. 23 -- Epitracker Inc has submitted a patent application for Fatty Acid Analogs and Their Use in the Treatment of Cognitive Impairment, Behavioral Conditions, and Chronic Pain. This invention was developed by Venn-watson Stephanie. The patent application number is US202519303055 20250818. The patent publicatio..

Acelink Therapeutics Inc Applies for Patent on Crystalline Forms of a Glucosylceramide Synthase Inhibitor and Uses Thereof

Pharmaceutical

| Mon 23 Feb 2026

Alexandria, Feb. 23 -- Acelink Therapeutics Inc has applied United States patent for Crystalline Forms of a Glucosylceramide Synthase Inhibitor and Uses Thereof. Zheng Jianhong, Wang Xiaoyang and He Hongyan developed it. The patent application number is US202319104233 20230810. The patent publication number is US20260048036 (..

Forward Therapeutics Inc Files United States Patent Application for Modulators of TNF-alpha Activity

Pharmaceutical

| Mon 23 Feb 2026

Alexandria, Feb. 23 -- Forward Therapeutics Inc has filed a patent application for Modulators of TNF-alpha Activity. This invention was developed by Kanouni Toufike and Fukase Yoshiyuki. The patent application number is US202519370127 20251027. The patent publication number is US20260048035 (A1). International Patent Classifi..

CereSpir Submits United States Patent Application for Polymorphs of Co-crystals of Itanapraced and Nicotinamide

Pharmaceutical

| Mon 23 Feb 2026

Alexandria, Feb. 23 -- CereSpir has submitted a patent application for Polymorphs of Co-crystals of Itanapraced and Nicotinamide. This invention was developed by Chain Daniel, Forster Matt, Margolin Richard and Mueller Ronald. The patent application number is US202519210006 20250516. The patent publication number is US2026004..

Li Weihao Applies for Patent on Intelligent Identifying and Sorting Method and System for Traditional Chinese Medicinal Materials

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Li Weihao has applied Chinese patent for Intelligent Identifying and Sorting Method and System for Traditional Chinese Medicinal Materials. Li Weihao and Hong So-young developed it. The patent application number is CN202510770542 20250610. The patent publication number is CN120599426 (A). International Pat..

State Intellectual Property Office of China Releases Jiangsu Fubang Pharmaceutical Co Ltd Patent Application for Mixing Device for Medicinal Cream Processing

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- State Intellectual Property Office of China has released Jiangsu Fubang Pharmaceutical Co Ltd patent application for Mixing Device for Medicinal Cream Processing. This invention was developed by Jiang Heping, Liu Jianhua, Huang Jinyou and Zhou Weijun. The patent application number is CN202510696546 2025052..

Shandong Lingkai Pharmaceutical Co Ltd Submits Patent Application for Method for Continuously Preparing Sulfuryl Fluoride Through Fluidized Bed

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Shandong Lingkai Pharmaceutical Co Ltd has submitted a patent application for Method for Continuously Preparing Sulfuryl Fluoride Through Fluidized Bed. Wen Qiao, Wang Jinbao and Cui Zesheng developed the invention. The patent application number is CN202511113040 20250811. The patent publication number is ..

Beijing Taikaier Nutrition Tech Development Co Ltd Files Chinese Patent Application for Packaging Equipment for Production of Monascus Herbal Ointment and Method Thereof

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Beijing Taikaier Nutrition Tech Development Co Ltd has filed a patent application for Packaging Equipment for Production of Monascus Herbal Ointment and Method Thereof. This invention was developed by Jiang Hongying. The patent application number is CN20251125594 20250724. The patent publication number is ..

State Intellectual Property Office of China Releases Imworks Pty Ltd Patent Application for Oncolytic Viruses as Therapeutic Agents for Treatment of Cancer

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- State Intellectual Property Office of China has released Imworks Pty Ltd patent application for Oncolytic Viruses as Therapeutic Agents for Treatment of Cancer. This invention was developed by Shafren David. The patent application number is CN20248009530 20240208. The patent publication number is CN1206039..

Shandong Simcere Biological Pharmaceutical Co Ltd Seeks Patent for Bispecific Antibodies Against MUC17 and CD3 and Uses Thereof

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Shandong Simcere Biological Pharmaceutical Co Ltd has sought patent for Bispecific Antibodies Against MUC17 and CD3 and Uses Thereof. This invention was developed by Cheng Guangcun, Fu Yayuan and Tang Renhong. The patent application number is CN20248010087 20240202. The patent publication number is CN12060..

Shanghai Medgen Biopharma Tech Co Ltd Applies for Patent on Pharmaceutical Composition of FAP/CD40 Binding Molecule and Medical Application Thereof

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Shanghai Medgen Biopharma Tech Co Ltd has applied Chinese patent for Pharmaceutical Composition of FAP/CD40 Binding Molecule and Medical Application Thereof. Wu Hui, Yan Yijie, Zhao Zhilong and Li Lei developed it. The patent application number is CN20248009926 20240223. The patent publication number is CN..

Bianshi Biological Pharmaceutical Co Ltd Applies for Patent on IL-2 Mutants and Uses Thereof

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Bianshi Biological Pharmaceutical Co Ltd has applied Chinese patent for IL-2 Mutants and Uses Thereof. Xiao Shouhua, Feng Weijun, Dai Yumin, Xue Jie and Zhai Halei developed it. The patent application number is CN20238087207 20231129. The patent publication number is CN120603842 (A). International Patent C..

State Intellectual Property Office of China Releases Chengdu Chipscreen Pharmaceutical Ltd Patent Application for Diheterocyclic WRN Inhibitor as Well as Preparation Method and App..

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- State Intellectual Property Office of China has released Chengdu Chipscreen Pharmaceutical Ltd patent application for Diheterocyclic WRN Inhibitor as Well as Preparation Method and Application Thereof. This invention was developed by Wang Wei, Sun Xiaoyang, Liu Ziqiang, Zhang Jixin, Qing Ying, Zhang Ping, Liu..

State Intellectual Property Office of China Releases Neurostrix Pharmaceuticals Inc Patent Application for Novel Pyrrolo [1, 2-D] [1, 2, 4] Triazin-1-one Derivatives as Negative Al..

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- State Intellectual Property Office of China has released Neurostrix Pharmaceuticals Inc patent application for Novel Pyrrolo [1, 2-D] [1, 2, 4] Triazin-1-one Derivatives as Negative Allosteric Modulators of mGlu7 Receptor. This invention was developed by Paparin Jean-laurent, Rocher Jean-philippe, Rootjes Flo..

Laikai Pharmaceutical Ningbo Co Ltd Seeks Patent for Fused Polycyclic Compounds and Their Use as PARP1 Inhibitors

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Laikai Pharmaceutical Ningbo Co Ltd has sought patent for Fused Polycyclic Compounds and Their Use as PARP1 Inhibitors. This invention was developed by Li Ming, Chen Yan, Chen Junyan and Gu Xiangju Justin. The patent application number is CN20238078093 20231108. The patent publication number is CN120603832..

Inocur Therapeutics Inc Submits Chinese Patent Application for Degradation Agent for Degrading cMET Protein and Pharmaceutical Composition Comprising Same

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Inocur Therapeutics Inc has submitted a patent application for Degradation Agent for Degrading cMET Protein and Pharmaceutical Composition Comprising Same. This invention was developed by Yoo Hye-dong, Shin Young-jun, Kim Bo-kyoung, Yang Dong-sik and Kuk Seung-hoon. The patent application number is CN20238..

Alumis Applies for Patent on Crystalline Forms of TYK2 Inhibitors and Uses Thereof

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Alumis has applied Chinese patent for Crystalline Forms of TYK2 Inhibitors and Uses Thereof. Bay Karlheinz and Remachuk Tomasz developed it. The patent application number is CN20238078220 20231010. The patent publication number is CN120603822 (A). International Patent Classification codes are A61K31/4439, ..

Petignovo Biopharma Inc Applies for Patent on Process for Preparation of Delta-tocotrienols

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Petignovo Biopharma Inc has applied Chinese patent for Process for Preparation of Delta-tocotrienols. Castali Gianfranco, Castalli Marco and Zambon Massimo developed it. The patent application number is CN20238093583 20231229. The patent publication number is CN120603819 (A). International Patent Classific..

Mwenger Therapeutics Inc Submits Chinese Patent Application for NLRP3 Inhibitors

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Mwenger Therapeutics Inc has submitted a patent application for NLRP3 Inhibitors. This invention was developed by Rogovoy Boris, Kisil Vladimir and Satchuk Nikolay. The patent application number is CN20248009325 20240124. The patent publication number is CN120603818 (A). International Patent Classification..

Shenyang Haisco Pharmaceutical Co Ltd Files Chinese Patent Application for Preparation Method of Chiral Amino Alcohol Medical Intermediate

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Shenyang Haisco Pharmaceutical Co Ltd has filed a patent application for Preparation Method of Chiral Amino Alcohol Medical Intermediate. This invention was developed by Jiang Xi, Dou Ying, Fan Jiang, Hu Jianyong and Lin Hanwen. The patent application number is CN20248008063 20240117. The patent publicatio..

State Intellectual Property Office of China Receives Posida Therapeutics Inc Patent Application for Lipid Compounds and Related Compositions and Uses

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- State Intellectual Property Office of China has received Posida Therapeutics Inc patent application for Lipid Compounds and Related Compositions and Uses. Huang Lijun, Li Ling, Vemuri Gopal N and Hajj Karoly A developed the invention. The patent application number is CN20248008444 20240119. The patent publ..

Shanghai Huanma Biological Medical Co Ltd Submits Chinese Patent Application for Lipid Compound, Lipid Nanoparticle and Pharmaceutical Composition

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Shanghai Huanma Biological Medical Co Ltd has submitted a patent application for Lipid Compound, Lipid Nanoparticle and Pharmaceutical Composition. This invention was developed by Yang Yun, Li Zeyang and Zhang Kai. The patent application number is CN20248008629 20240207. The patent publication number is CN..

Inner Mongolia Autonomous Region Zhongmeng Medicine Res Institute Submits Chinese Patent Application for Application of Treasure Pill in Preparation of Medicine for Preventing Cere..

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Inner Mongolia Autonomous Region Zhongmeng Medicine Res Institute has submitted a patent application for Application of Treasure Pill in Preparation of Medicine for Preventing Cerebral Apoplexy. This invention was developed by Xia Yaobin, Sichenbateer, Liu Jingzhou, Zhou Baoguo, Guo Ningning, Liu Qi, Na Buqi,..

Piaoqishi Biotechnology Co Ltd Submits Patent Application for Mannuronates, Guluronates, and Guluronate Topical Gels or Creams and Methods of Making Same

Pharmaceutical

| Sun 22 Feb 2026

Beijing, Feb. 23 -- Piaoqishi Biotechnology Co Ltd has submitted a patent application for Mannuronates, Guluronates, and Guluronate Topical Gels or Creams and Methods of Making Same. Mirshafiei Afshin and Lalande Julien developed the invention. The patent application number is CN20238092453 20231222. The patent publication nu..

Beijing Jingjia Biological Tech Co Ltd Submits Chinese Patent Application for Application of Whey Protein in Preparation of Medicine for Resisting Epilepsy-related Depression

Pharmaceutical

| Mon 23 Feb 2026

Beijing, Feb. 23 -- Beijing Jingjia Biological Tech Co Ltd has submitted a patent application for Application of Whey Protein in Preparation of Medicine for Resisting Epilepsy-related Depression. This invention was developed by Wang Hongxing, Lyu Dingyi and Du Huanhuan. The patent application number is CN202510979321 20250716..

1 to 100 of 1845 Items Next >>

Home
|
About Us
|
Privacy Policy
|
Support
|
Products
|
Careers
|
Contact Us

© Copyright 2015. All Right Reserved.

Email selected articles